References
- Yuzpe A A., Smith R P., Rademaker A W. A mukicenter clinical investigation employing ethinylestradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 1982; 37: 508–13
- Trussel J, Stewart F. The effectiveness of postcoital hormonal contraception. Fam Plann Perspect 1992; 24: 262–4
- Task Force on Post-ovulatory Methods for Fertility Regulation, WHO. Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Contraception 1987; 36: 275–86
- Ho P C., Kwan M SW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod 1993; 8: 389–92
- Zuliani G, Colombo U F., Molla R. Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens. Eur J Obstet Gynecol Reprod Biol 1990; 37: 253–60
- Webb A MC, Russel J, Elstein M. Comparison of Yuzpe regime, danazol and mifepristone in oral postcoital contraception. Br Med J 1992; 305: 927–31
- Von Hertzen H, Van Look P FA. Alternative methods of emergency contraception. Fertil Control Rev 1995; 4: 22–5
- Glasier A, Thong K J., Dewar M, Mackie M, Baird D. Mifepristone (RU486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992; 327: 1041–4
- Van Look P FA, von Hertzen H. Clinical uses of antiprogestogens. Hum Reprod Update 1995; 1: 19–34